Starting Hypertension Treatment

Setting Targets
  • Michael A. Weber
Part of the Current Clinical Practice book series (CCP)


Guidelines on when to start antihypertensive treatment have been published recently. The Sixth Joint National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure (INC VI) (1) and the World Health Organization—International Society of Hypertension (2) have provided very similar criteria to assist decision making. Table 17-1 presents the JNC VI recommendations.


Hypertensive Patient Lifestyle Modification Sodium Reduction Hypertension Optimal Treatment Reduce Sodium Intake 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Joint National Committee (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 157: 2413–2446.Google Scholar
  2. 2.
    Guidelines Subcommittee (1999) 1999 World Health Organization—International Society of Hypertension Guidelines for the Management of Hypertension. J Hyper-tens 17: 151–183.Google Scholar
  3. 3.
    The Trials of Hypertension Prevention Collaborative Research Group (1997) Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: The Trials of Hypertension Prevention, phase II. Arch Intern Med 157: 657–667.Google Scholar
  4. 4.
    Whelton PK, He J, Cutler JA, et al. (1997) Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 277: 16241632.Google Scholar
  5. 5.
    Hansson L, Zanchetti A, Carruthers SG, et al. (1998) Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet 351: 1755–1762.PubMedCrossRefGoogle Scholar
  6. 6.
    Bakris GL (1998) Progression of diabetic nephropathy: a focus on arterial pressure level and methods of reduction. Diabetes Res Clin Pract 39 (Suppl.): S35 — S42.PubMedCrossRefGoogle Scholar
  7. 7.
    UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS.38.BMJ 317: 703–713.Google Scholar
  8. 8.
    Burt VL, Whelton PK, Roccella EJ, et al. (1995) Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey 1988–1991. Hypertension 25: 305–313.PubMedCrossRefGoogle Scholar
  9. 9.
    Berlowitz DR, Ash AS, Hickey EC, et al. (1998) Inadequate management of blood pressure in a hypertensive population. N Engl J Med 339: 1957–1963.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Michael A. Weber

There are no affiliations available

Personalised recommendations